To include your compound in the COVID-19 Resource Center, submit it here.

Roche acquires rights to Antisoma's pipeline

Roche (SWX:ROCZ) received exclusive worldwide rights to develop, manufacture and market Antisoma's oncology pipeline. The deal includes Antisoma's Pemtumomab, which is

Read the full 211 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE